XML 46 R35.htm IDEA: XBRL DOCUMENT v3.21.2

Segment and Related Information (Tables)

9 Months Ended

Sep. 30, 2021

Segment Reporting [Abstract]

Schedule of Segment Revenue and Operating Income (Loss)

Segment revenue and operating income (loss) were as follows during the periods presented:

(in millions)			Diagnostics						Other						Total
Three months ended September 30, 2021
Revenues			$	161.7					$	5.6					$	167.3
Depreciation and amortization			13.1						1.1						14.2
Segment operating loss			(21.7)						(58.2)						(79.9)
Three months ended September 30, 2020
Revenues			$	130.5					$	14.7					$	145.2
Depreciation and amortization			16.7						1.0						17.7
Segment operating loss			(0.3)						(39.3)						(39.6)
Nine months ended September 30, 2021
Revenues			$	496.6					$	33.2					$	529.8
Depreciation and amortization			45.8						3.7						49.5
Segment operating income (loss)			26.3						(173.7)						(147.4)
Nine months ended September 30, 2020
Revenues			$	362.0					$	40.4					$	402.4
Depreciation and amortization			50.2						3.1						53.3
Segment operating loss			(127.7)						(113.9)						(241.6)

			Three months ended September 30,															Nine months ended September 30,
(in millions)			2021									2020						2021									2020
Total operating loss for reportable segments			$	(79.9)								$	(39.6)					$	(147.4)								$	(241.6)
Unallocated amounts:
Interest income			0.2									0.4						0.6									1.7
Interest expense			(1.1)									(2.9)						(6.1)									(8.3)
Other			120.6									(1.6)						139.3									14.9
Income (loss) from operations before income taxes			39.8									(43.7)						(13.6)									(233.3)
Income tax expense (benefit)			15.2									(28.5)						6.0									(47.4)
Net income (loss)			24.6									(15.2)						(19.6)									(185.9)
Net loss attributable to non-controlling interest			—									—						—									(0.1)
Net income (loss) attributable to Myriad Genetics, Inc. stockholders			$	24.6								$	(15.2)					$	(19.6)								$	(185.8)

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration